HIRSCHMAN ORIN 13D/13G Filings for Cellectar Biosciences, Inc. (CLRB)

HIRSCHMAN ORIN 13D and 13G filings for Cellectar Biosciences, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2025-01-27
10:07 am
Sale		 2024-12-31 13G Cellectar Biosciences, Inc.
CLRB		 HIRSCHMAN ORIN 2,022,221
4.900%		 -640,103decrease
(-24.04%)		 Filing
2024-02-07
6:58 pm
Purchase		 2024-01-23 13G Cellectar Biosciences, Inc.
CLRB		 HIRSCHMAN ORIN 2,662,324
8.700%		 747,104increase
(+39.01%)		 Filing
2023-12-05
06:01 am
Purchase		 2023-11-07 13G Cellectar Biosciences, Inc.
CLRB		 HIRSCHMAN ORIN 1,915,220
9.900%		 1,915,220increase
(New Position)		 Filing